Ignite Creation Date:
2024-05-06 @ 2:08 AM
Last Modification Date:
2024-10-26 @ 11:14 AM
Study NCT ID:
NCT01971281
Status:
UNKNOWN
Last Update Posted:
2017-09-13
First Post:
2013-10-23
Brief Title:
Safety Feasibility and Effect of TTFields 150 kHz Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma PANOVA
Sponsor:
Organization:
NovoCure Ltd